Your browser doesn't support javascript.
loading
Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.
Trifan, Anca; Burta, Ovidiu; Tiuca, Nicoleta; Petrisor, Diana Corina; Lenghel, Augustin; Santos, Javier.
Affiliation
  • Trifan A; SC Gastromedica SRL, Iasi, Romania.
  • Burta O; Department of Internal Medicine, Municipal Hospital Dr. Gavril Curteanu, Oradea, Romania.
  • Tiuca N; Department of Internal Medicine, University Emergency Hospital Bucharest, Romania.
  • Petrisor DC; Endodigest Medical Clinic, Oradea, Romania.
  • Lenghel A; CMI Augustin Lenghel, Oradea, Romania.
  • Santos J; Digestive System Research Unit, University Hospital Vall d'Hebron, Spain.
United European Gastroenterol J ; 7(8): 1093-1101, 2019 10.
Article in En | MEDLINE | ID: mdl-31662866

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Oligosaccharides / Xylans / Irritable Bowel Syndrome / Diarrhea / Demulcents / Pea Proteins / Glucans Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies Country/Region as subject: Europa Language: En Journal: United European Gastroenterol J Year: 2019 Type: Article Affiliation country: Romania

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Oligosaccharides / Xylans / Irritable Bowel Syndrome / Diarrhea / Demulcents / Pea Proteins / Glucans Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies Country/Region as subject: Europa Language: En Journal: United European Gastroenterol J Year: 2019 Type: Article Affiliation country: Romania